Medical Services & Publications

Roche's Itovebi Doubles Progression-Free Survival in Advanced Breast Cancer

Submitted by newsonline24.c… on Tue, 11/05/2024 - 21:00

SHERIDAN, WYOMING – NOVEMBER 05, 2024 – In a landmark phase III study published in the New England Journal of Medicine, Roche's Itovebi (inavolisib) has demonstrated a significant breakthrough in the treatment of HR-positive advanced breast cancer. The Itovebi-based regimen more than doubled progression-free survival compared to the standard treatment of palbociclib and fulvestrant alone. The INAVO120 study evaluated Itovebi in combination with palbociclib and fulvestrant in patients with HR-positive, HER2-negative breast cancer with a PIK3CA mutation, one of the most common mutations in this type of cancer. The results were striking, with the Itovebi-based regimen reducing the risk of disease progression or death by 57%. [cite: 1, 2, 7]

Sheridan-Based Company Makes Strides in Weight Management Technology

Submitted by newsonline24.c… on Tue, 11/05/2024 - 17:08

SHERIDAN, WYOMING – November 05, 2024 – A Sheridan-based company is at the forefront of a revolution in weight management, offering individuals a path to a healthier lifestyle through innovative technological solutions. The company, though details remain undisclosed, is working on a system that leverages the power of Glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that regulates appetite and blood sugar. GLP-1 has garnered significant attention in recent years for its potential to promote weight loss and improve metabolic health. "We're incredibly excited about the possibilities this technology presents," a company spokesperson shared. "GLP-1's ability to regulate appetite and blood sugar holds immense promise for individuals struggling with weight management."

Staying Healthy in the Face of the Longevity Boom

Submitted by newsonline24.c… on Tue, 11/05/2024 - 16:55

SHERIDAN, WYOMING – November 05, 2024-With all the buzz around the "longevity boom" it can be easy to get caught up in the latest trends and fads. But what does it really take to live a long and healthy life? This article explores the insights of three doctors on achieving longevity. Keeping it Simple: The Basics Still Matter Dr. David Lipman, a leading physician, emphasizes that focusing on the basics of healthy living remains paramount. Getting enough sleep, eating a nutritious diet, and exercising regularly are all well-established pillars of longevity. "While there may be new discoveries on the horizon," says Dr. Lipman, "we shouldn't neglect the tried-and-true methods that we know work."Looking Beyond the Trees: A Holistic Approach

Taiwan Showcases AI-Powered Medical Innovations at MEDICA 2024

Submitted by J. Mikhail on Wed, 10/30/2024 - 23:59

SHERIDAN, WYOMING – October 30, 2024 – Taiwan is set to make a significant impact on the medical technology landscape at MEDICA 2024, showcasing cutting-edge AI-powered surgical innovations alongside a wide range of advanced medical devices. From November 11-14 at Messe Düsseldorf, 17 leading Taiwanese companies will unveil 28 groundbreaking products, highlighting Taiwan's position as a frontrunner in global healthcare innovation.

GS1 Germany: Your Partner for UDI Compliance in Medical Devices

Submitted by J. Mikhail on Fri, 10/18/2024 - 00:55

SHERIDAN, WYOMING – October 18, 2024 – As the deadline for Unique Device Identification (UDI) compliance approaches, medical device manufacturers are seeking reliable solutions to meet the regulatory requirements. GS1 Germany, an accredited UDI issuing agency, offers comprehensive support and resources to help manufacturers navigate the complexities of UDI implementation.

What is Unique Device Identification (UDI)?

Subscribe to Medical Services & Publications